129 related articles for article (PubMed ID: 16281308)
1. New pyrimido[5,4-c]cinnolines with antiplatelet activities.
Rehse K; Gonska H
Arch Pharm (Weinheim); 2005 Dec; 338(12):590-7. PubMed ID: 16281308
[TBL] [Abstract][Full Text] [Related]
2. New purines with antiplatelet activity.
Märschenz K; Rehse K
Arch Pharm (Weinheim); 2006 Mar; 339(3):115-22. PubMed ID: 16493596
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiplatelet activity of new imidazole-4-carboxylic acid derivatives.
Rehse K; Steege J
Arch Pharm (Weinheim); 2005 Nov; 338(11):539-47. PubMed ID: 16281307
[TBL] [Abstract][Full Text] [Related]
4. New 1H-pyrazole-4-carboxamides with antiplatelet activity.
Rehse K; Kotthaus J; Khadembashi L
Arch Pharm (Weinheim); 2009 Jan; 342(1):27-33. PubMed ID: 19051198
[TBL] [Abstract][Full Text] [Related]
5. New 2-amino-thiazole-4-acetamides with antiplatelet activity.
Rehse K; Baselt T
Arch Pharm (Weinheim); 2008 Oct; 341(10):645-54. PubMed ID: 18720337
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro antiplatelet activity and molecular modelling studies of 10-substituted 2-(1-piperazinyl)pyrimido[1,2-a]benzimidazol-4(10H)-ones.
Di Braccio M; Grossi G; Signorello MG; Leoncini G; Cichero E; Fossa P; Alfei S; Damonte G
Eur J Med Chem; 2013 Apr; 62():564-78. PubMed ID: 23425969
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and inhibitory activities on platelet aggregation of some flavonoid analogues.
Göker H; Tunçbilek M; Leoncini G; Buzzi E; Mazzei M; Rolland Y; Ertan R
Arzneimittelforschung; 1995 Feb; 45(2):150-5. PubMed ID: 7710437
[TBL] [Abstract][Full Text] [Related]
10. Modulation of platelet and leucocyte function by a Chinese herbal formulation as compared with conventional antiplatelet agents.
Zhao L; Gaudry L; Dunkley S; Brighton T; Guo ZX; Ye ZL; Luo RZ; Chesterman CN
Platelets; 2008 Feb; 19(1):24-31. PubMed ID: 18231935
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of chalcone analogs as potential inhibitors of ADP- and collagen-induced platelet aggregation.
Vijaya Bhaskar Reddy M; Tsai WJ; Qian K; Lee KH; Wu TS
Bioorg Med Chem; 2011 Dec; 19(24):7711-9. PubMed ID: 22055718
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
13. Antiaggregating and antithrombotic activities of new 1, 2, 3-triazolecarboxamides.
Cwiklicki A; Rehse K
Arch Pharm (Weinheim); 2004 Mar; 337(3):156-63. PubMed ID: 15038061
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and structure-activity relationships of a novel series of 5-alkylidenepyridazin-3(2H)-ones with a non-cAMP-based antiplatelet activity.
Coelho A; Raviña E; Fraiz N; Yáñez M; Laguna R; Cano E; Sotelo E
J Med Chem; 2007 Dec; 50(26):6476-84. PubMed ID: 18031002
[TBL] [Abstract][Full Text] [Related]
16. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
[TBL] [Abstract][Full Text] [Related]
17. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG
Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
Wang WY; Hsieh PW; Wu YC; Wu CC
Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
[TBL] [Abstract][Full Text] [Related]
19. A comparative optical aggregometry study of antiplatelet activity of taxanes from Taxus cuspidata.
Kim SY; Yun-Choi HS
Thromb Res; 2010 Jun; 125(6):e281-4. PubMed ID: 20170941
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-platelet evaluation of 2-benzoylaminobenzoate analogs.
Hsieh PW; Chiang SZ; Wu CC; Lo YC; Shih YT; Wu YC
Bioorg Med Chem; 2008 May; 16(10):5803-14. PubMed ID: 18407506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
